All In Biotech

Drug Trial Radar · NCT00412971

A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer

A Randomized, Comparative Phase III, 2-center Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer

Last checked: Nov 20, 2026Latest source record: Oct 11, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 233 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

233

Actual

Start

Apr 2005

Primary completion

Oct 2008

Study completion Oct 2008

Sponsor

Lead sponsor
PhotocureIndustry
Sponsor type
Industry
First posted
Dec 19, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objective of the study is to compare the 1-year recurrence rate of Hexvix assisted Transuretheral Resection of the Bladder (TURB) to standard white light TURB in patients with suspicion of non-invasive bladder cancer. The hypothesis is to test whether the 1-year recurrence rate is different with Hexvix assisted TURB compared to standard white light TURB.

Conditions

  • Bladder Cancer

Interventions

  • HexvixDrug

    Single installation, TURB

  • Standard white light cystoscopyOther

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Patients With Histologically Confirmed Recurrence Within One 1 Year.Time frame: 1 year

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Frederiksberg Hospital

    Frederiksberg, Denmark

  • Odense University Hospital

    Odense, Denmark

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.